CBD Life Sciences Inc. Announces Its New Product "CBD Pre-Rolls"

SCOTTSDALE, AZ / ACCESSWIRE / May 13, 2020 / CBD Life Sciences Inc. CBDL through its wholly owned subsidiary, LBC Bioscience Inc. is pleased to announce that our new product "CBD Pre-Rolls "arrived to our Facility and is readily available to be purchased. The product consists of 1 gram of CBD Hemp Flower that contains less than 0.3% of THC. The product is meant to be smoked so users can instantly feel the effects of CBD such as pain relief, anxiety relief, stress relief and more! The product is retailing for $14.99 and consumers can place their order today on our website www.lbcbioscienceinc.com.

The CBD "(cannabidiol) market is rapidly growing and has shown promising indication for the health & wellness industry. Widespread use is increasing throughout the public. Follow our social media accounts at www.instagram.com/lbcbioscience www.linkedin.com/company/lbcbioscienceinc & www.twitter.com/lbcbioscience for updating information.

Lisa Nelson, President/CEO of CBD Life Sciences, Inc. commented "We are pleased to announce that our new product (CBD Pre-Rolls) are available for consumers to purchase. Users can instantly feel the benefits of CBD while smoking our CBD Pre-Roll. I am looking forward to our customers trying out our latest product and giving us feedback."

Lisa Nelson continued "CBD Pre-Rolls are the hottest Cannabidiol products on the market and we strive to bring our consumers the highest quality of CBD." Lisa ended with "The Company will continue to update the public about new product releases, trades shows, events and any updated information regarding LBC Bioscience Inc."

About LBC Bioscience Inc.

LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including: CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.

Ten Associates LLC

Contact: Thomas E. Nelson

Telephone: (480) 326-8577

Email: tenassociates33@gmail.com

Website: www.tenassociatesllc.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.

SOURCE: CBD Life Sciences Inc.